Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 130,133 | -120,548 | -122,993 | -131,445 | -4,682 |
| Depreciation Amortization | 5,119 | 5,019 | 3,998 | 2,583 | 1,247 |
| Income taxes - deferred | -6,014 | N/A | -12,661 | N/A | N/A |
| Accounts receivable | -50,608 | -1,099 | 166 | -4,080 | 124 |
| Accounts payable and accrued liabilities | 20,097 | -19,913 | -11,875 | 13,584 | 6,203 |
| Other Working Capital | -58,287 | -44,774 | -65,314 | -53,531 | 171,891 |
| Other Operating Activity | 73,367 | 32,708 | 23,285 | -2,739 | 9,993 |
| Operating Cash Flow | $113,807 | $-148,607 | $-185,394 | $-175,628 | $184,776 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -155,785 | 169,671 | 50,750 | 18,483 | -116,446 |
| PPE Investments | -70 | -95 | -228 | -231 | -575 |
| Investing Cash Flow | $-155,855 | $169,576 | $50,522 | $18,252 | $-117,021 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 12,529 | 145,905 | N/A | N/A |
| Debt Repayment | -1,285 | -14,533 | -2,280 | -2,016 | -1,859 |
| Common Stock Issued | N/A | 732 | 7,987 | 3,624 | 114 |
| Common Stock Repurchased | -941 | -972 | -1,679 | -621 | -357 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 70 |
| Financing Cash Flow | $-2,226 | $-2,244 | $149,933 | $987 | $-2,032 |
| Beginning Cash Position | 80,386 | 61,661 | 46,600 | 202,989 | 137,266 |
| End Cash Position | 36,112 | 80,386 | 61,661 | 46,600 | 202,989 |
| Net Cash Flow | $-44,274 | $18,725 | $15,061 | $-156,389 | $65,723 |
| Free Cash Flow | |||||
| Operating Cash Flow | 113,807 | -148,607 | -185,394 | -175,628 | 184,776 |
| Capital Expenditure | -70 | -95 | -228 | -231 | -910 |
| Free Cash Flow | 113,737 | -148,702 | -185,622 | -175,859 | 183,866 |